Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II01:27

Pneumothorax-II

852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.1K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Influences of Tibial Plateau Morphology on JLCA Change, Clinical Outcomes and Cartilage Regeneration After Medial Opening Wedge High Tibial Osteotomy.

Orthopaedic journal of sports medicine·2026
Same author

Transcription factor BHLHE40 expression in group 3 innate lymphoid cells and RORγt⁺ antigen-presenting cells coordinates intestinal immunity.

Immunity·2026
Same author

A STAT1/ETC/GBP1 axis represents a potential therapeutic target for noncommunicable granulomatous skin disease.

Science advances·2026
Same author

Cardiolipin preserves T<sub>reg</sub> metabolic fitness and immune homeostasis in the gut.

Nature metabolism·2026
Same author

IDH1 Mutations Are Associated with Favorable Outcomes in Prostate Cancer.

European urology·2026
Same author

Robust Non-Invasive Cardiac Index Prediction via Feature Integration and Data-Augmented Neural Networks.

Bioengineering (Basel, Switzerland)·2026

関連する実験動画

Updated: Jan 9, 2026

Pulmonary Embolism III: Nursing Management
01:27

Pulmonary Embolism III: Nursing Management

Published on: June 19, 2025

320

ミトコンドリア ダイナミクスは 代謝 プログラムを通して T 細胞の運命を制御する

Michael D Buck1, David O'Sullivan2, Ramon I Klein Geltink2

  • 1Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.

Cell
|June 14, 2016
PubMed
まとめ

ミトコンドリアダイナミクスはT細胞の代謝を制御する. メモリT細胞の融合したミトコンドリアは脂肪酸の酸化を促進し,エフェクターT細胞の断片化されたミトコンドリアは,抗腫瘍免疫に影響を及ぼします.

さらに関連する動画

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Published on: June 19, 2025

277
Pulmonary Embolism I: Introduction
01:29

Pulmonary Embolism I: Introduction

Published on: June 19, 2025

464

関連する実験動画

Last Updated: Jan 9, 2026

Pulmonary Embolism III: Nursing Management
01:27

Pulmonary Embolism III: Nursing Management

Published on: June 19, 2025

320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Published on: June 19, 2025

277
Pulmonary Embolism I: Introduction
01:29

Pulmonary Embolism I: Introduction

Published on: June 19, 2025

464

科学分野:

  • 免疫学
  • 細胞生物学
  • 代謝に関する研究

背景:

  • エフェクタ T (TE) 細胞は,アナボリック代謝 (有酸素糖解) を利用する.
  • メモリーT (TM) 細胞は,代謝 (脂肪酸酸化 - FAO) を利用する.
  • T細胞におけるこれらの代謝の違いを誘発するシグナルは完全に理解されていません.

研究 の 目的:

  • T細胞の代謝プログラムにおけるミトコンドリア動力の役割を調査する.
  • ミトコンドリア構造がT細胞の機能と代謝に影響するかどうかを判断する.

主な方法:

  • TE細胞とTM細胞におけるミトコンドリア形態の比較分析
  • T細胞におけるミトコンドリア融合 (Opa1) の遺伝子操作.
  • 代謝経路 (糖分解,FAO,OXPHOS) とT細胞機能の評価

主要な成果:

  • TE細胞はピントされた (断片化された) ミトコンドリアを示し,TM細胞は融合したミトコンドリアネットワークを示します.
  • 融合タンパク質Opa1はTM細胞のミトコンドリア構造に不可欠である.
  • TE細胞におけるミトコンドリア融合の強化により,TM細胞の代謝特性と抗腫瘍活性が強化された.
  • ミトコンドリア融合は,FAOの電子輸送チェーン (ETC) の効率を最適化します.
  • TE細胞のミトコンドリア分裂は結晶の膨張につながり,ETCの効率を低下させ,糖分解を促進する.

結論:

  • ミトコンドリアの改造,特に融合と分裂は,T細胞の代謝プログラミングを指示する重要なメカニズムです.
  • ミトコンドリアの動態の変化は,T細胞の代謝経路とエフェクター機能に直接影響を及ぼします.
  • ミトコンドリアのダイナミクスをターゲットにすることで 抗腫瘍T細胞の反応を高めることができます